Martin Cannon is the founder of Hemanext. Hemanext has raised $130M in total funding. Latest round: Series B. Based in Lexington, Massachusetts.
Martin Cannon founded Hemanext, a medical technology company focused on transfusion medicine and blood storage systems. He led the company through several successful funding rounds, raising over $130 million in total capital, before retiring after a $25 million Series B1 round.
Full founder directory · Investor directory · Company funding database · Fundraising library